177 related articles for article (PubMed ID: 1900225)
41. Hemostatic activation and outcome after recombinant tissue plasminogen activator therapy for acute ischemic stroke.
Tanne D; Macko RF; Lin Y; Tilley BC; Levine SR;
Stroke; 2006 Jul; 37(7):1798-804. PubMed ID: 16763191
[TBL] [Abstract][Full Text] [Related]
42. Comparison of double bolus urokinase versus front-loaded alteplase regimen for acute myocardial infarction. Thrombolysis in Myocardial Infarction in Korea (TIMIKO) study group.
Park SJ
Am J Cardiol; 1998 Sep; 82(6):811-3, A10. PubMed ID: 9761098
[TBL] [Abstract][Full Text] [Related]
43. Newer thrombolytic drugs for acute myocardial infarction.
Reddy DS
Indian J Exp Biol; 1998 Jan; 36(1):1-15. PubMed ID: 9536645
[TBL] [Abstract][Full Text] [Related]
44. Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction. The RAPID II Investigators.
Bode C; Smalling RW; Berg G; Burnett C; Lorch G; Kalbfleisch JM; Chernoff R; Christie LG; Feldman RL; Seals AA; Weaver WD
Circulation; 1996 Sep; 94(5):891-8. PubMed ID: 8790022
[TBL] [Abstract][Full Text] [Related]
45. Association between plasmin activation system and intravascular ultrasound signs of plaque instability in patients with unstable angina and non-st-segment elevation myocardial infarction.
Gyöngyösi M; Glogar D; Weidinger F; Domanovits H; Laggner A; Wojta J; Zorn G; Iordanova N; Huber K
Am Heart J; 2004 Jan; 147(1):158-64. PubMed ID: 14691435
[TBL] [Abstract][Full Text] [Related]
46. Circadian variations of onset of acute myocardial infarction and efficacy of thrombolytic therapy.
Kono T; Morita H; Nishina T; Fujita M; Hirota Y; Kawamura K; Fujiwara A
J Am Coll Cardiol; 1996 Mar; 27(4):774-8. PubMed ID: 8613602
[TBL] [Abstract][Full Text] [Related]
47. Relative efficacy of antithrombin compared with antiplatelet agents in accelerating coronary thrombolysis and preventing early reocclusion.
Haskel EJ; Prager NA; Sobel BE; Abendschein DR
Circulation; 1991 Mar; 83(3):1048-56. PubMed ID: 1900222
[TBL] [Abstract][Full Text] [Related]
48. Thrombolytic agents for acute evolving myocardial infarction: comparative effects.
Sherry S
Ration Drug Ther; 1987 Jan; 21(1):1-9. PubMed ID: 3112866
[No Abstract] [Full Text] [Related]
49. Thrombolytic treatment in acute myocardial infarction.
Acar J; Vahanian A; Michel PL; Slama M; Cormier B; Roger V
Semin Thromb Hemost; 1987 Apr; 13(2):186-200. PubMed ID: 2957791
[No Abstract] [Full Text] [Related]
50. Recombinant single-chain urokinase-type plasminogen activator during acute myocardial infarction.
Diefenbach C; Erbel R; Pop T; Mathey D; Schofer J; Hamm C; Ostermann H; Schmitz-Hübner U; Bleifeld W; Meyer J
Am J Cardiol; 1988 May; 61(13):966-70. PubMed ID: 2452563
[TBL] [Abstract][Full Text] [Related]
51. New thrombolytic drugs in acute myocardial infarction: theoretical and practical considerations.
Verstraete M
Circulation; 1987 Aug; 76(2 Pt 2):II31-8. PubMed ID: 3111745
[No Abstract] [Full Text] [Related]
52. Platelet function during and after thrombolytic therapy for acute myocardial infarction with reteplase, alteplase, or streptokinase.
Moser M; Nordt T; Peter K; Ruef J; Kohler B; Schmittner M; Smalling R; Kübler W; Bode C
Circulation; 1999 Nov; 100(18):1858-64. PubMed ID: 10545429
[TBL] [Abstract][Full Text] [Related]
53. [Thrombolytic therapy].
Matsuda T
Nihon Rinsho; 1998 Oct; 56(10):2577-81. PubMed ID: 9796322
[TBL] [Abstract][Full Text] [Related]
54. Serial thrombolysis-related changes after thrombolytic therapy with TPA in patients with acute myocardial infarction.
Ho CH; Wang SP
Thromb Res; 1990 May; 58(3):331-41. PubMed ID: 1693793
[TBL] [Abstract][Full Text] [Related]
55. [Coronary thrombolysis in patients with acute myocardial infarction].
Kambara H; Fudo T; Ono S
Kokyu To Junkan; 1992 Jun; 40(6):537-47. PubMed ID: 1620990
[No Abstract] [Full Text] [Related]
56. Usefulness of intravenous thrombolytic therapy with pro-urokinase in acute myocardial infarction.
Bode C; Schuler G; Schwarz F; Zimmermann R; Horn A; Kuebler W
Am J Cardiol; 1987 Aug; 60(4):371. PubMed ID: 3113225
[No Abstract] [Full Text] [Related]
57. Thrombolytic therapy.
Collen D; Lijnen HR
Ann N Y Acad Sci; 1991; 614():259-69. PubMed ID: 1902640
[No Abstract] [Full Text] [Related]
58. [Plasminogen activators as thrombolytic agents in myocardial infarction].
Chamone DA; Massumoto C; Fujimura AY; Pileggi F; Bellotti G
Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(6):288-94. PubMed ID: 2518605
[TBL] [Abstract][Full Text] [Related]
59. Combinations of thrombolytic agents in acute myocardial infarction.
Bode C; Baumann H; von Hodenberg E; Freitag M; Nordt T
Z Kardiol; 1993; 82 Suppl 2():125-8. PubMed ID: 8328189
[TBL] [Abstract][Full Text] [Related]
60. A randomized trial of recombinant staphylokinase versus alteplase for coronary artery patency in acute myocardial infarction. The STAR Trial Group.
Vanderschueren S; Barrios L; Kerdsinchai P; Van den Heuvel P; Hermans L; Vrolix M; De Man F; Benit E; Muyldermans L; Collen D
Circulation; 1995 Oct; 92(8):2044-9. PubMed ID: 7554180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
